Dr. Serge Carrier is professor in the Department of Surgery, Division of Urology at McGill University, Montreal, Canada. Dr. Carrier is a urologist at McGill University Health Center. Dr Carrier is the fellowship director of the McGill Sexual Medicine/Genitourinary Reconstructive Urology Fellowship.
Dr. Carrier obtained his medical diploma from the Laval University (Quebec, Canada) where he also completed his urology residency. Dr. Carrier then completed his training as a post-doctoral fellow in andrology, sexual medicine and neurourology at the University of California, San Francisco with Dr Tom F. Lue and Emile Tanagho. His Major Academic Focus and areas of research: Men’s health, Reproduction and Hypogonadism, Sexual and bladder dysfunction, Prostate Health and BPH. He has published over hundred papers.
Dr. Carrier is the president-elect of Sexual Medicine Society of North America. Dr Carrier is a past-president of the Quebec Urological Association, the Société Francophone de Médecine Sexuelle as well as of the Canadian Male Sexual Health Council. He also is a peer reviewer for many journals.
Mohit Khera, M.D., M.B.A., M.P.H. earned his undergraduate degree at Vanderbilt University. He subsequently earned his Masters Degree in Business Administration and his Masters Degree in Public Health from Boston University. He received his Medical Degree from The University of Texas Medical School at San Antonio and completed his Urology residency training in the Scott Department of Urology at Baylor College of Medicine. After finishing a six-year residency in Urology, he completed a one-year fellowship in Male Reproductive Medicine and Surgery. Currently a Professor in the Scott Department of Urology at Baylor College of Medicine, he specializes in male and female sexual dysfunction and hormone replacement therapy. Dr. Khera also serves as the Director of the Laboratory for Andrology Research, the Medical Director of the Baylor Executive Health Program and the Faculty Group Practice Medical Director of the Scott Department of Urology. Dr. Khera was also appointed the F. Brantley Scott Chair in Urology.
Dr. Khera has dedicated his clinical and research efforts to three main areas: testosterone, erectile dysfunction, and Peyronie’s disease. Soon after completing my fellowship he started the Laboratory for Andrology Research. His laboratory focuses on basic science research on testosterone and its effects on the prostate, stem cells to treat erectile dysfunction, the effects of finasteride on sexual function, and genetic markers of hypogonadism. In his laboratory he has had the opportunity to train many residents and research fellows. In addition to his basic science research, he has initiated numerous FDA approved clinical trials. His basic science and clinic experiences have allowed him to thus far give over 200 lectures at scientific meetings, publish over 100 articles in peer reviewed journals, complete 15 book chapters, and edit and write two books all in the field of sexual medicine.
In 2007 he was awarded the American Urologic Association (AUA) Research Scholars Award to study the correlation between ED and BPH. In 2013 he was elected to serve a 4 year term on the American Urologic Society Examination Committee. Dr. Khera has also served on the AUA Peyronie’s Disease and Erectile Dysfunction Guidelines Panel. For the past several years he has taught numerous course in testosterone therapy and sexual dysfunction nationally and throughout the world. Finally, Dr. Khera currently serves as the Secretary of the Sexual Medicine Society of North America.
Dr. Khera freely shares his time and knowledge with the general public. He has been voted one of Houston’s Best Doctors by Health and Sport Fitness Magazine and by Houstonia Magazine and is a frequent guest on such TV programs as Fox News’ “Ask the Doctor.” He also writes a blog on Men’s Health for the Houston Chronicle Newspaper.
Tobias S. Kohler, M.D., is a urologist, with specialty interest and fellowship training in men's health (andrology). He has published more than 150 peer-reviewed scientific articles, book chapters and scientific abstracts and presented both locally and nationally on various subjects, including erectile dysfunction, low testosterone, BPH, surgical education and penile prostheses. He was co-editor for two textbooks: Contemporary Treatment of Erectile Dysfunction, Second Edition, and Surgeons as Educators: A Guide for Academic Development and Teaching Excellence. He recently authored "Wilson's Pearls, Perils and Pitfalls of Penile Prosthesis Surgery." Dr. Kohler is a physician trainer for penile prosthesis surgery in the United States and in Europe. He is a member of the Prospective Registry of Outcomes With Penile Prosthesis for Erectile Restoration (PROPPER) Study — sponsored by American Medical Systems/Boston Scientific. Dr. Kohler is the founder of the soon to be launched Erectile Restoration Outcomes Study (EROS, sponsored by Coloplast) penile implant registry. In addition to his clinical and research activities, Dr. Kohler is active in education, providing mentorship to residents and fellows. Dr. Kohler is the director for the Mayo Clinic Andrology Fellowship program.
Christian Nelson is a clinical psychologist with expertise in treating men with prostate cancer and other genitourinary malignancies. As the psychological liaison to Memorial Sloan Kettering’s genitourinary and sexual medicine services, he provides short- and long-term counseling services to patients struggling with cancer-related issues. Dr. Nelson also works with the Center’s 65+ Program, providing psychological support for patients who are 65 and older, and co-facilitates a support group for patients dealing with the combined issues of cancer and aging.
Working with members of the symptom management, neurocognitive, and psychotherapy laboratories, Dr. Nelson has focused his research on cancer’s impact on quality of life in prostate and geriatric cancer patients, and on developing new psychotherapy approaches for these groups. Some specific studies he has conducted include the impact of sexual dysfunction following cancer treatment; the cognitive effects of hormonal therapy on prostate cancer patients; distress in African-American men with prostate cancer; and developing assessment measures and psychotherapy specific to geriatric patients.
Dr. Hossein Sadeghi-Nejad graduated Magna Cum Laude from Bowdoin College in Brunswick, Maine where he was the recipient of the Goodwin Commencement Prize. He received his medical doctorate from the McGill University School of Medicine in Montreal, Canada and served as an Intern and Resident in General Surgery at the University of California in San Francisco. Dr. Sadeghi-Nejad completed his urological residency and fellowship training in Male Reproductive Medicine and microsurgery at the Boston University Medical Center under the auspices of Drs. Robert Krane, Irwin Goldstein, and Robert Oates.
Dr. Sadeghi-Nejad is Professor of Surgery / Urology at Rutgers New Jersey Medical School, Chief of Urology at the VA NJ Health Care System, and the Director of the Center for Male Reproductive Medicine at the Hackensack University Medical Center. Dr. Sadeghi-Nejad has served as a member of the American Urological Association global task force and has been selected for multiple editions of Top Doctors: New York Metro Area, New Jersey Monthly magazine’s "Best Doctors in New Jersey" and NY Magazine Top Doctors 2020. He is one of only a handful of New Jersey urologists listed on Castle Connolly's America’s Top Doctors since 2012. Dr. Sadeghi-Nejad is certified by the American Board of Urology and is a member of numerous professional organizations including the American Urological Association, The Sexual Medicine Society of North America (SMSNA), the International Society of Sexual Medicine (ISSM) the Society for Study of Male Reproduction, and the American Society of Reproductive Medicine (ASRM). He is a scientific reviewer for numerous peer-reviewed journals and serves on the editorial board of the Journal of Sexual Medicine. Dr. Sadeghi-Nejad is the president of SMSNA and is a member of the Board of Directors. In 2015, he was the recipient of SMSNA’s highest distinction, the Distinguished Service Award.
Dr. Sadeghi-Nejad has been a participant in multiple Plenary Sessions of the American Urological Association Annual Meeting and is a co-author of the 2014 United States Surgeon General’s Report. From 2011 to 2015, he was a member of the Board of Directors of the NY Section of the American Urological Association as the New Jersey representative. From 2015 to 2019, Dr. Sadeghi-Nejad served as a member of the American Urological Association Guidelines Panel, a group tasked with preparation of evidence-based practice guidelines for urologists in the United States. He was recently selected to serve as the Associate Editor in charge of Men’s Health for the AUA News, the official newsletter of the American Urological Association. Dr. Sadeghi-Nejad is one of 16 members of the American Board of Urology Examination Committee.
Amy I. Guise, MD is an Associate Professor of Urology at the Medical College of Wisconsin in Milwaukee. She graduated from Indiana University School of Medicine in 2005, completed Urology Residency at the Medical College of Wisconsin in 2010, and a mini-endurology fellowship at IU Health Methodist Hospital in 2013. Her practice focuses on benign prostatic hyperplasia and male sexual dysfunction. Dr. Guise serves as the Assistant Chief of Urology at the VA Medical Center in Milwaukee.
Dr. Lawrence C. Jenkins received his MD from the University of Buffalo School of Medicine and Biomedical Sciences. He finished his urology training at the University of Miami and followed that with a fellowship in Male Sexual and Reproductive Medicine at Memorial Sloan-Kettering Cancer Center and the Center for Male Reproductive Medicine and Microsurgery at the Weill Medical College of Cornell University in New York, NY. Dr. Jenkins previously practiced at the Ohio State University Department of Urology from where he focused on male sexual and reproductive medicine.
Dr. Justin Parker is an urologist in Tampa, Florida and is affiliated with multiple hospitals in the area, including Florida Hospital Tampa and James A. Haley Veterans’ Hospital-Tampa. He received his medical degree from University of South Florida College of Medicine and has been in practice between 6-10 years. He is one of 20 doctors at Florida Hospital Tampa and one of 13 at James A. Haley Veterans’ Hospital-Tampa who specialize in Urology.
Dr. Kelvin Davies joined the Einstein Department of Urology in 2001 as a basic scientist with a research background in biochemistry and molecular biology. Since 2009 he has had a joint faculty position in the Departments of Physiology and Biophysics. Overall his research applies biochemical and molecular mechanisms to understand urogenital pathology, particularly the role of smooth muscle in the development of urogenital pathology. The primary goal of these basic science studies is clinical translation and Dr. Davies’s work has resulted in the first and only FDA approved clinical trials of gene therapy to treat benign urologic disease (over-active bladder and erectile dysfunction (ED)).
At present the two major interests of his lab are the role of potassium channels in bladder and erectile function, and the role of opiorphin is erectile physiology and priapism. Collaboration with other researchers has been a hallmark of Dr. Davies’s research and he has collaborated and published with several other researchers at Einstein in such diverse areas as the use of NO-encapsulating nanoparticles for treatment of ED, peripheral nerve regeneration as a possible treatment for ED resulting from nerve damage associated with radical prostatectomy, the role of opiorphins in prostate cancer and the impact of opiorphins synthesized in the erectile tissue on systemic blood-pressure as a potential link between ED and cardiovascular disease.
His work has been funded by several grants; he has been Principal Investigator on 7 NIH grants and is currently Principal Investigator on an NIH R01 and two NY State Department of Health grants.
Faysal A. Yafi, MD, FRCSC, is the medical director of the Department of Urology Men’s Health Program at UC Irvine Health. He specializes in andrology (men’s health), which includes the treatment of male sexual dysfunction, male infertility, low testosterone, Peyronie’s disease, male voiding dysfunction, and prosthetic surgery.
Dr. Yafi received his medical degree from the American University of Beirut in Lebanon. Subsequently, he transferred to the Mayo Clinic in Rochester, MN, to complete an internship in general surgery. Yafi pursued a clinical research fellowship followed by a residency in urology at McGill University Health Center in Montreal, Canada. He then completed a two-year fellowship in andrology and prosthetic surgery at Tulane University School of Medicine in New Orleans.
Dr. Yafi has been a recipient of research grants from the Sexual Medicine Society of North America and the Quebec Urological Association, which allowed him to further study the prevention and treatment of Peyronie's disease and erectile dysfunction. He has received awards and recognition for his research and has been an invited guest speaker at various national and international conferences. He is published in more than 80 peer-reviewed publications. A well-connected urologist, Yafi is an active member of the International Society for Sexual Medicine, the Sexual Medicine Society of North America, the American Society of Andrology, the American Urological Association, and the Société Internationale d'Urologie. Also, he is a fellow of the Royal College of Surgeons of Canada.
Dr. Wittmann is an Associate Professor of Urology and Adjunct Associate Professor of Social Work. She is a lead faculty in the Brandon Prostate Cancer Survivorship Program with clinical and research interest is sexual health and quality of life in cancer survivorship. She uses mixed methods to understand issues in cancer survivorship care and to evaluate interventions designed to improve patients' and partners' outcomes. She is faculty in the Mixed Methods Research Program at the University of Michigan.
Dr. Lawrence S. Hakim is Chairman of the Department of Urology and Director of the Center for Surgical Specialties at Cleveland Clinic Florida. Dr. Hakim served as President of the SMSNA from 2014 to 2016 and serves on the board of numerous national and international professional societies. Dr. Hakim received his medical degree from the State University of New York Health Science Center at Brooklyn (SUNY Downstate Medical Center). His postgraduate training includes residencies in surgery and urology and a chief residency at SUNY Downstate Medical Center. He completed his post-graduate fellowship training in sexual medicine, infertility, andrology, and microsurgery at Boston University School of Medicine. Dr. Hakim is an international recognized leader in male and female sexual medicine and surgery, hypogonadism, male infertility, and prosthetics.
Dr. Trost completed his undergraduate education at Brigham Young University, where he graduated magna cum laude and valedictorian. He underwent medical school training at Tulane University in New Orleans, Louisiana, where he received top grades in all subjects.
Dr. Trost completed residency training in urology at Mayo Clinic in Rochester, Minnesota, and did fellowships in male infertility and sexual function at Tulane University, University of Florida at Winterhaven and Memorial Sloan Kettering Cancer Center. From 2012 to 2019 Dr. Trost served as the chief of male infertility at the Mayo Clinic in Rochester, Minnesota. In July 2019 he founded the Male Fertility and Peyronie’s Clinic in Orem, Utah.
Dr. Trost is one of only a few surgeons trained in both traditional microscopic vasectomy reversals as well as robotic-assisted repair of the vas deferens. In addition to training, Dr. Trost has significant experience with vasectomy reversals and performs up to five reversals weekly.
He regularly publishes and lectures on topics of male infertility and sexual function, and has a particular interest in the field of male infertility, and currently serves as an associate editor for the Journal of Sexual Medicine.